Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Quantitative Characterization of the Prostatic Urethra Using MRI: Implications for Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia
  2. Sanford, Thomas H; Harmon,Stephanie; Kesani, Deepak; Gurram, Sandeep; Gupta, Nikhil; Mehralivand, Sherif; Sackett, Jonathan; Wiener, Scott; Wood, Bradford J; Xu, Sheng; Pinto, Peter A; Choyke, Peter L; Turkbey, Baris
  3. Academic radiology. 2021, May; 28(5): 664-670.
  1. 2.   RB inactivation in keratin 18 positive thymic epithelial cells promotes non-cell autonomous T cell hyperproliferation in genetically engineered mice
  2. Song, Yurong; Sullivan, Teresa; Klarmann, Kimberly; Gilbert, Debra; O'Sullivan, Theresa; Lu, Lucy; Wang, Sophie; Haines, Diana; Van Dyke, Terry; Keller, Jonathan
  3. PLOS ONE. 2017, Feb 3; 12(2): e0171510.
  1. 3.   The Role of Estrogen Receptor alpha and beta in Regulating Vascular Smooth Muscle Cell Proliferation is Based on Sex
  2. Hogg, M. E.; Vavra, A. K.; Banerjee, M. N.; Martinez, J.; Jiang, Q.; Keefer, L. K.; Chambon, P.; Kibbe, M. R.
  3. Journal of Surgical Research. 2012, Mar; 173(1): E1-E10.
  1. 4.   Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia
  2. Vavra, A. K.; Havelka, G. E.; Martinez, J.; Lee, V. R.; Fu, B.; Jiang, Q.; Keefer, L. K.; Kibbe, M. R.
  3. Nitric Oxide-Biology and Chemistry. 2011, Jun; 25(1): 22-30.
  1. 5.   Nitric Oxide Inhibits Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia by Increasing the Ubiquitination and Degradation of UbcH10
  2. Tsihlis, N. D.; Oustwani, C. S.; Vavra, A. K.; Jiang, Q.; Keefer, L. K.; Kibbe, M. R.
  3. Cell Biochemistry and Biophysics. 2011, Jun; 60(1-2): 89-97.
  1. 6.   Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status
  2. Hogg, M. E.; Varu, V. N.; Vavra, A. K.; Popowich, D. A.; Banerjee, M. N.; Martinez, J.; Jiang, Q.; Saavedra, J. E.; Keefer, L. K.; Kibbe, M. R.
  3. Free Radical Biology and Medicine. 2011, May; 50(9): 1065-1074.
  1. 7.   Poly(diol-co-citrate)s as Novel Elastomeric Perivascular Wraps for the Reduction of Neointimal Hyperplasia
  2. Serrano, M. C.; Vavra, A. K.; Jen, M.; Hogg, M. E.; Murar, J.; Martinez, J.; Keefer, L. K.; Ameer, G. A.; Kibbe, M. R.
  3. Macromolecular Bioscience. 2011, May; 11(5): 700-709.
  1. 8.   Urinary Estrogen Metabolites and Prostate Cancer Risk: A Pilot Study
  2. Kosti, O.; Xu, X.; Veenstra, T. D.; Hsing, A. W.; Chu, L. W.; Goldman, L.; Bebu, I.; Collins, S.; Dritschilo, A.; Lynch, J. H.; Goldman, R.
  3. Prostate. 2011, Apr; 71(5): 507-516.
  1. 9.   Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes
  2. Varu, V. N.; Ahanchi, S. S.; Hogg, M. E.; Bhikhapurwala, H. A.; Chen, A.; Popowich, D. A.; Vavra, A. K.; Martinez, J.; Jiang, Q.; Saavedra, J. E.; Hrabie, J. A.; Keefer, L. K.; Kibbe, M. R.
  3. American Journal of Physiology-Heart and Circulatory Physiology. 2010, Sep; 299(3): H772-H779.
  1. 10.   Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasia
  2. Kapadia, M. R.; Chow, L. W.; Tsihlis, N. D.; Ahanchi, S. S.; Hrabie, J. A.; Murar, J.; Martinez, J.; Popowich, D. A.; Jiang, Q.; Hrabie, J. A.; Saavedra, J. E.; Keefer, L. K.; HUlvat, J. F.; Stupp, S. I.; Kibbe, M. P.
  3. Journal of Vascular Surgery. 2008 47(1): 173-182.
  1. 11.   Another piece of the p27(Kip1) puzzle
  2. Kaldis, P.
  3. Cell. 2007, Jan; 128(2): 241-244.
  1. 12.   Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
  2. Matyakhina, L.; Freedman, R. J.; Bourdeau, I.; Wei, M. H.; Stergiopoulos, S. G.; Chidakel, A.; Walther, M.; bu-Asab, M.; Tsokos, M.; Keil, M.; Toro, J.; Linehan, W. M.; Stratakis, C. A.
  3. Journal of Clinical Endocrinology & Metabolism. 2005, JUN; 90(6): 3773-3779.
  1. 13.   Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh)
  2. Raafat, A.; Bargo, S.; Anver, M. R.; Callahan, R.
  3. Oncogene. 2004, DEC 16; 23(58): 9401-9407.
  1. 14.   Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: Role of inclusion body formation
  2. Waalkes, M. P.; Liu, J.; Goyer, R. A.; Diwan, B. A.
  3. Cancer Research. 2004, NOV 1; 64(21): 7766-7772.
  1. 16.   Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee
  2. Shappell, S. B.; Thomas, G. V.; Roberts, R. L.; Herbert, R.; Ittmann, M. M.; Rubin, M. A.; Humphrey, P. A.; Sundberg, J. P.; Rozengurt, N.; Barrios, R.; Ward, J. M.; Cardiff, R. D.
  3. Cancer Research. 2004 64(6): 2270-2305.
  1. 17.   A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia
  2. Webber, M. M.; Trakul, N.; Thraves, P. S.; Bello-DeOcampo, D.; Chu, W. W.; Storto, P. D.; Huard, T. K.; Rhim, J. S.; Williams, D. E.
  3. Carcinogenesis. 1999 20(7): 1185-1192.
  1. 18.   Expression of Kai1 in Paraffin-Embedded Normal, Hyperplastic and Neoplastic Prostate and Prostate Carcinoma Cell Lines
  2. Ward, J. M.; Konishi, N.; Ohshima, M.; Lamb, P. W.; Jorcyk, C. L.; Barrett, J. C.
  3. Pathology International. 1998 48(2): 87-92.
  1. 19.   Increased Udp-Glucuronosyltransferase Activity and Decreased Prostate Specific Antigen Production By Biochanin a in Prostate Cancer Cells
  2. Sun, X. Y.; Plouzek, C. A.; Henry, J. P.; Wang, T. T. Y.; Phang, J. M.
  3. Cancer Research. 1998 58(11): 2379-2384.
  1. 20.   Effect of Oncogene Expression On Telomerase Activation and Telomere Length in Human Endothelial, Fibroblast and Prostate Epithelial Cells
  2. Burger, A. M.; Fiebig, H. H.; Kuettel, M. R.; Lautenberger, J. A.; Kung, H. F.; Rhim, J. S.
  3. International Journal of Oncology. 1998 13(5): 1043-1048.
  1. 21.   Information Analysis of Human Splice Site Mutations
  2. Rogan, P. K.; Faux, B. M.; Schneider, T. D.
  3. Human Mutation. 1998 12(3): 153-171.
  1. 22.   Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen
  2. Diwan, B. A.; Anderson, L. M.; Ward, J. M.
  3. Annual Meeting of the American Association for Cancer Research. 1997, 38 A3105.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel